| RS2106206598 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome |
| RS2106208285 |
CHRND
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 3B, Lethal multiple pterygium syndrome |
| RS2106209945 |
FARSB
|
Health Risk |
Pathogenic |
Rajab interstitial lung disease with brain calcifications 1, Rajab interstitial lung disease with brain calcifications 1 |
| RS2106211133 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106217873 |
DIS3L2
|
Health Risk |
Likely pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106220457 |
CUL3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without autism or seizures, Neurodevelopmental disorder with or without autism or seizures |
| RS2106220741 |
CUL3
|
Health Risk |
Pathogenic |
— |
| RS2106220804 |
DIS3L2
|
Health Risk |
Pathogenic/Likely pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106220962 |
CUL3
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS2106221030 |
CUL3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2106221493 |
DIS3L2
|
Health Risk |
Likely pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106221588 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106221597 |
CHRNG
|
Health Risk |
Likely pathogenic |
Autosomal recessive multiple pterygium syndrome, Autosomal recessive multiple pterygium syndrome |
| RS2106221927 |
CHRNG
|
Health Risk |
Pathogenic |
Autosomal recessive multiple pterygium syndrome, Autosomal recessive multiple pterygium syndrome |
| RS2106221995 |
CHRNG
|
Health Risk |
Likely pathogenic |
Autosomal recessive multiple pterygium syndrome, Autosomal recessive multiple pterygium syndrome |
| RS2106223392 |
CUL3
|
Health Risk |
Pathogenic |
— |
| RS2106223532 |
CUL3
|
Health Risk |
Likely pathogenic |
— |
| RS2106223664 |
CUL3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without autism or seizures, Neurodevelopmental disorder with or without autism or seizures |
| RS2106223668 |
CUL3
|
Health Risk |
Pathogenic |
CUL3-related disorder, Inborn genetic diseases |
| RS2106223773 |
CUL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without autism or seizures, Neurodevelopmental disorder with or without autism or seizures |
| RS2106223782 |
CUL3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without autism or seizures, Neurodevelopmental disorder with or without autism or seizures |
| RS2106226183 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106226493 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS2106230623 |
FARSB
|
Health Risk |
Pathogenic |
Rajab interstitial lung disease with brain calcifications 1, Rajab interstitial lung disease with brain calcifications 1 |
| RS2106232915 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106235905 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Benign familial hematuria |
| RS2106236091 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS2106236126 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106236191 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106237105 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2106239691 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106239900 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106246658 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106246712 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106247498 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS2106247510 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2106247623 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106250143 |
ZNF142
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with impaired speech and hyperkinetic movements, Neurodevelopmental disorder with impaired speech and hyperkinetic movements |
| RS2106250495 |
FN1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2106250696 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106250767 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106250807 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2106261987 |
PDE6D
|
Health Risk |
Pathogenic |
Joubert syndrome 22, Joubert syndrome 22 |
| RS2106264503 |
CUL3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without autism or seizures, Neurodevelopmental disorder with or without autism or seizures |
| RS2106264622 |
CUL3
|
Health Risk |
Pathogenic |
— |
| RS2106264887 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106264934 |
DIS3L2
|
Health Risk |
Likely pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106267339 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2106267620 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106271012 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2106271092 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106274329 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hematuria, benign familial |
| RS2106274574 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106281153 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106283830 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Alport syndrome, Alport syndrome 3b |
| RS2106284079 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2106284607 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106288671 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2106289464 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106291953 |
MLPH
|
Health Risk |
Likely pathogenic |
Griscelli syndrome type 3, Griscelli syndrome type 3 |
| RS2106294164 |
PDE6D
|
Health Risk |
Pathogenic |
Joubert syndrome 22, Joubert syndrome 22 |
| RS2106295155 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome 3b, autosomal recessive |
| RS2106297951 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2106298115 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2106303300 |
MAP3K20
|
Health Risk |
Likely pathogenic |
MAP3K20-related disorder, MAP3K20-related disorder |
| RS2106304000 |
CUL3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without autism or seizures, Neurodevelopmental disorder with or without autism or seizures |
| RS2106304006 |
CUL3
|
Health Risk |
Likely pathogenic |
— |
| RS2106304068 |
CUL3
|
Health Risk |
Pathogenic |
— |
| RS2106304517 |
CUL3
|
Health Risk |
Likely pathogenic |
— |
| RS2106308424 |
IHH
|
Health Risk |
Pathogenic |
— |
| RS2106308536 |
IHH
|
Health Risk |
Likely pathogenic |
— |
| RS2106308616 |
IHH
|
Health Risk |
Likely pathogenic |
— |
| RS2106309194 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106309216 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS2106310580 |
IHH
|
Health Risk |
Pathogenic |
Brachydactyly type A1, Brachydactyly type A1 |
| RS2106310688 |
IHH
|
Health Risk |
Pathogenic |
— |
| RS2106312317 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2106314700 |
COL6A3
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2106317762 |
COL6A3
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS2106318158 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS2106319784 |
COL6A3
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS2106320090 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS2106320484 |
BCS1L
|
Health Risk |
Pathogenic/Likely pathogenic |
GRACILE syndrome, GRACILE syndrome |
| RS2106322191 |
BCS1L
|
Health Risk |
Likely pathogenic |
— |
| RS2106324466 |
BCS1L
|
Health Risk |
Likely pathogenic |
Mitochondrial complex III deficiency nuclear type 1, GRACILE syndrome |
| RS2106324666 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2106324972 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2106325341 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2106325851 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS2106325859 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS2106328711 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS2106328737 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS2106329063 |
BCS1L
|
Health Risk |
Likely pathogenic |
— |
| RS2106329218 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS2106329494 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS2106329702 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS2106332781 |
BCS1L
|
Health Risk |
Likely pathogenic |
Pili torti-deafness syndrome, Pili torti-deafness syndrome |
| RS2106337664 |
MAP3K20
|
Health Risk |
Pathogenic |
— |
| RS2106338008 |
SCN1A-AS1;SCN9A
|
Health Risk |
Likely pathogenic |
— |
| RS2106341060 |
COL6A3
|
Health Risk |
Likely pathogenic |
— |